INCREASED ANGIOTENSIN CONVERTING ENZYME IN MURINE SCHISTOSOMIASIS - EFFECTS OF CAPTOPRIL AND MK-421

被引：0
|
作者：
SILVERSTEIN, E
EVELAND, LK
FRIEDLAND, J
STANEK, AE
DIAMOND, HS
BUSH, ME
COHEN, L
机构：
[1] SUNY DOWNSTATE MED CTR,DEPT MED,BROOKLYN,NY 11203
[2] SUNY DOWNSTATE MED CTR,DEPT PATHOL,BROOKLYN,NY 11203
[3] SUNY DOWNSTATE MED CTR,DEPT MICROBIOL & IMMUNOL,BROOKLYN,NY 11203
来源：
CLINICAL RESEARCH | 1982年 / 30卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A404 / A404
页数：1
相关论文
共 50 条
  • [31] EFFECTS OF CONVERTING ENZYME-INHIBITION WITH MK-421 ON BLOOD-PRESSURE, RENAL HEMODYNAMICS AND SODIUM HANDLING
    DEGOEDE, WJ
    GEYSKES, GG
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1983, 5 (06) : 345 - 345
  • [32] ENALAPRIL MALEATE (MK-421), A POTENT, NONSULFHYDRYL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR - ABSORPTION, DISPOSITION, AND METABOLISM IN MAN
    ULM, EH
    DRUG METABOLISM REVIEWS, 1983, 14 (01) : 99 - 110
  • [33] CONCOMITANT BLOCKADE AND ACTIVATION OF THE RENIN-ALDOSTERONE SYSTEM BY AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR (MK-421) AND HYDROCHLOROTHIAZIDE
    GRIFFING, GT
    MELBY, JC
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1982, 32 (03): : 396 - 405
  • [34] A COMPARISON OF THE ACTIVITY OF THE ANGIOTENSIN CONVERTING ENZYME-INHIBITORS SQ-14-225, SA-446, AND MK-421
    TAKATA, Y
    DINICOLANTONIO, R
    MENDELSOHN, FAO
    HUTCHINSON, JS
    DOYLE, AE
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1983, 10 (02) : 131 - 145
  • [35] EFFECTS IN HEALTHY-SUBJECTS OF A NEW NON-THIOL-CONTAINING ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, ENALAPRIL MALEATE (MK-421)
    NAKASHIMA, M
    NISHIJIMA, K
    CLINICAL SCIENCE, 1982, 63 : S183 - S185
  • [36] COMPARISON OF ANGIOTENSIN CONVERTING ENZYME-INHIBITORS CAPTOPRIL AND MK421-DIACID IN GUINEA-PIG ATRIA
    NAKASHIMA, A
    ANGUS, JA
    JOHNSTON, CI
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 81 (03) : 487 - 492
  • [37] ALTERATION OF THE GRANULOMATOUS RESPONSE IN MURINE SCHISTOSOMIASIS BY THE CHRONIC ADMINISTRATION OF CAPTOPRIL, AN INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME
    WEINSTOCK, JV
    BOROS, DL
    GASTROENTEROLOGY, 1981, 81 (05) : 953 - 958
  • [38] ACUTE EFFECTS OF MK421, A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, IN MAN
    KASAI, Y
    ABE, K
    YASUJIMA, M
    TAJIMA, J
    SEINO, M
    CHIBA, S
    SATO, K
    GOTO, T
    OMATA, K
    TANNO, M
    YOSHINAGA, K
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 141 (04): : 417 - 422
  • [39] EFFECT OF CAPTOPRIL, MK-421 AND MK-422 ON FIBRINOLYSIS DETERMINED BY 3 INVITRO ASSAYS
    TSAO, C
    GARDNER, DV
    GALLUZZO, TS
    MOLTENI, A
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1984, 267 (01): : 169 - 176
  • [40] EFFECT ON ENALAPRIL (MK-421) AND METOPROLOL (MTP) ON BLOOD-PRESSURE, CONVERTING ENZYME, RENIN, AND CATECHOLAMINES
    WINER, N
    CARTER, CH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) : 232 - 232
12345